68 related articles for article (PubMed ID: 21137236)
1. [Risk factors and long-term results of radiotherapy in grade-3 and -4 brain neoplasms].
Ismaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2010; 56(5):565-70. PubMed ID: 21137236
[TBL] [Abstract][Full Text] [Related]
2. [The role of functional status and recursive partition analysis (RPA) classes for the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):369-73. PubMed ID: 22888653
[TBL] [Abstract][Full Text] [Related]
3. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
4. Assessment of compliance to treatment and efficacy of a resource-sparing hypofractionated radiotherapy regimen in patients with poor-prognosis high-grade gliomas.
Gupta T; Dutta D; Trivedi S; Upasani M; Jalali R; Sarin R
J Cancer Res Ther; 2010; 6(3):272-7. PubMed ID: 21119252
[TBL] [Abstract][Full Text] [Related]
5. [The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):374-9. PubMed ID: 22888654
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with multiple brain metastases treated with whole-brain radiotherapy.
Wong E; Tsao M; Zhang L; Danjoux C; Barnes E; Pulenzas N; Vuong S; Chow E
CNS Oncol; 2015; 4(4):213-24. PubMed ID: 26118428
[TBL] [Abstract][Full Text] [Related]
7. Whole brain radiation therapy in management of brain metastasis: results and prognostic factors.
Saito EY; Viani GA; Ferrigno R; Nakamura RA; Novaes PE; Pellizzon CA; Fogaroli RC; Conte MA; Salvajoli JV
Radiat Oncol; 2006 Jun; 1():20. PubMed ID: 16808850
[TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of symptomatic extracranial lesions on survival of recursive partitioning analysis Class III brain metastatic patients treated with stereotactic radiotherapy.
Chen XJ; Xiao JP; Li XP; Jiang XS; Zhang Y
J Cancer Res Ther; 2016; 12(1):215-20. PubMed ID: 27072240
[TBL] [Abstract][Full Text] [Related]
9. Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme.
Lee JH; Jung TY; Jung S; Kim IY; Jang WY; Moon KS; Jeong EH
J Clin Neurosci; 2013 Apr; 20(4):503-8. PubMed ID: 23313530
[TBL] [Abstract][Full Text] [Related]
10. A multivariate analysis of the prognostic factors of grade III gliomas.
Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
12. [The role of RPA classification in the treatment of high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV; Zotov VK
Vopr Onkol; 2012; 58(4):521-6. PubMed ID: 23607208
[TBL] [Abstract][Full Text] [Related]
13. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
14. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
15. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults.
Nakamura M; Konishi N; Tsunoda S; Nakase H; Tsuzuki T; Aoki H; Sakitani H; Inui T; Sakaki T
Oncology; 2000 Feb; 58(2):108-16. PubMed ID: 10705237
[TBL] [Abstract][Full Text] [Related]
18. Management of brain metastases from non-small cell lung cancer.
Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
[TBL] [Abstract][Full Text] [Related]
19. Fractionated radiotherapy in the management of benign vascular tumors.
Portnow LH; Scott M; Morris CG; Mendenhall WM; Marcus RB; Indelicato DJ
Am J Clin Oncol; 2012 Dec; 35(6):557-61. PubMed ID: 21659831
[TBL] [Abstract][Full Text] [Related]
20. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
